Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Sang Heon Lee, Jong Ho Moon*, Hyun Jong Choi, Hyung Ki Kim, Young Deok Cho, Moon Sung Lee, and Chan Sup Shim
Digestive Disease Center, Department of Internal Medicine, Soon Chun Hyang University School of Medicine, Bucheon and Seoul, Korea.
Correspondence to: Jong Ho Moon. Digestive Disease Center, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University School of Medicine, 1174, Jung-dong, Wonmi-gu, Bucheon 420-767, Korea. Tel: +82-32-621-5094, Fax: +82-32-621-5080, jhmoon@schbc.ac.kr
Gut Liver 2009;3(4):349-351. https://doi.org/10.5009/gnl.2009.3.4.349
Published online December 31, 2009, Published date December 31, 2009
Copyright © Gut and Liver.
Limy bile is a relatively rare condition in which a radiopaque material is visible in the gallbladder, extending rarely into the bile duct, on plain radiography. Acute cholangitis or cholecystitis caused by limy bile is a very rare condition. There are no definite treatment guidelines for limy bile, but in most cases with cholangitis or cholecystitis, laparoscopic cholecystectomy has been the preferred treatment. We report a case of limy bile with biliary symptoms that was treated only with an endoscopic procedure.
Keywords: Limy bile, Cholangitis, Cholecystitis, Endoscopic transpapillary gallbladder drainage
Limy bile is a rare disorder in which the gallbladder (GB) is filled with a thick paste-like radiopaque material, which extends rarely into the common bile duct (CBD).1,2 Since Churchman's description of this syndrome in 1911, more than 300 cases have been reported in the literature, including 7% with limy bile in both the GB and CBD.3 Tsukamoto et al.4 reported 26 cases in which obstructive jaundice was accompanied by limy bile. In cases with biliary symptoms accompanying limy bile, laparoscopic cholecystectomy is a less invasive option than open surgery, and its safety has been established.5 Nevertheless, patients still incur the risks associated with general anesthesia and longer hospital admission period.
We experienced a case of limy bile with acute cholangitis and cholecystitis that was treated with endoscopy without surgical intervention.
A 45-year-old female presented in the outpatient department with right upper quadrant pain, fever, and chills for 3 days duration. She did not have a specific medical treatment history. Laboratory findings were as follows: white blood cell count, 13,200/mm3; total/direct bilirubin, 7.73/5.52 mg/dL; gamma-glutamyl transferase, 797 IU/L; alkaline phosphatase, 232 IU/L; AST/ALT, 348/759 IU/L; and amylase/lipase, 49/32 IU/L.
Computed tomography showed high-density material in a dependent position of the GB and CBD. CBD dilatation was about 1.3 mm (Fig. 1). The patient was diagnosed with obstructive jaundice due to choledocholithiasis, which entails limy bile.
A duodenoscopy revealed diffusely enlarged major papilla. An endoscopic retrograde cholangiography (ERCP) revealed a 14-mm filling defect at the distal CBD. After an endoscopic sphincterectomy (EST), limy bile materials were washed out by sweeping with a balloon catheter (Fig. 2), and we inserted endoscopic nasobiliary drainage (ENBD). After then, clinical finding of the patient was improved dramatically, and surgical treatment such as a laparoscopic cholecystectomy was postponed. Four days after the first ERCP, we repeated the ERCP and again found a filling defect in the distal CBD. After completely removing limy bile from the CBD, we inserted a guide wire into the GB through the cystic duct, and a 7 Fr double-pigtail catheter (length, 15 cm) was introduced to the GB to evacuate limy bile (Fig. 3). The patient recovered completely after the endoscopic procedure.
Six months later, she was admitted for follow-up examination. During the follow up of six months, she was administered daily medication consisting of 600 mg of UDCA (Ursa®; Daewoong, Seoul, Korea) and 300 mg of a terpene preparation (Rowachol®; Rowa Pharma, Cork, Ireland). Laboratory findings were within normal ranges, and follow-up studies, including a CT, showed the complete evacuation of limy bile from the biliary system and GB (Fig. 4). The double-pigtail stent inserted to the GB was removed.
Limy bile is an uncommon condition in which the gallbladder and bile duct are filled with radiopaque material, readily noted on plain radiographs.1,2 Since the first description of this syndrome in 1911 by Churchman, more than 300 cases of limy bile have been reported.3
The presence of limy bile in the CBD is very rare, with only a few reported cases. Thus, when obstructive jaundice occurs with limy bile syndrome, there are no definite treatment guidelines. The most frequently used treatment to date is cholecystectomy; cholecystectomy is performed for limy bile in the GB, and cholecystectomy plus insertion of a T-tube into the CBD after removal of limy bile are performed for limy bile in the GB and the CBD.6 Recently, laparoscopic cholecystectomy for focal limy bile in the gallbladder has been reported,5 and a combined application of EST and laparoscopic cholecystectomy was used to treat limy bile in both the GB and CBD.7
In the present case, we performed EST to treat the cholangitis caused by biliary lithiasis. In most cases of limy bile syndrome, laparoscopic cholecystectomy is a safe procedure for treatment of acute cholecystitis. However, in patients at increased surgical risk, endoscopic drainage such as endoscopic transpapillary gallbladder drainage (ETGD) is an alternative treatment for acute cholecystitis.8,9 Itoi et al.9 reported that among 36 acute cholecystitis patients who received ETGD, 35 showed clinically favorable response without any serious procedure-related complications.
Given that limy bile is a movable precipitant of calcium carbonate combined with cholesterol,10 we postulated that ETGD could be used to drain limy bile and performed ETGD in this patient. Six months after the procedure, we observed complete evacuation of limy bile from the GB. Though surgery is the mainstay of the treatment for limy bile, endoscopic treatment such as EST and/or ETGD may be considered in selective patients, especially a high-risk candidate for operation.
Gut Liver 2009; 3(4): 349-351
Published online December 31, 2009 https://doi.org/10.5009/gnl.2009.3.4.349
Copyright © Gut and Liver.
Sang Heon Lee, Jong Ho Moon*, Hyun Jong Choi, Hyung Ki Kim, Young Deok Cho, Moon Sung Lee, and Chan Sup Shim
Digestive Disease Center, Department of Internal Medicine, Soon Chun Hyang University School of Medicine, Bucheon and Seoul, Korea.
Correspondence to: Jong Ho Moon. Digestive Disease Center, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University School of Medicine, 1174, Jung-dong, Wonmi-gu, Bucheon 420-767, Korea. Tel: +82-32-621-5094, Fax: +82-32-621-5080, jhmoon@schbc.ac.kr
Limy bile is a relatively rare condition in which a radiopaque material is visible in the gallbladder, extending rarely into the bile duct, on plain radiography. Acute cholangitis or cholecystitis caused by limy bile is a very rare condition. There are no definite treatment guidelines for limy bile, but in most cases with cholangitis or cholecystitis, laparoscopic cholecystectomy has been the preferred treatment. We report a case of limy bile with biliary symptoms that was treated only with an endoscopic procedure.
Keywords: Limy bile, Cholangitis, Cholecystitis, Endoscopic transpapillary gallbladder drainage
Limy bile is a rare disorder in which the gallbladder (GB) is filled with a thick paste-like radiopaque material, which extends rarely into the common bile duct (CBD).1,2 Since Churchman's description of this syndrome in 1911, more than 300 cases have been reported in the literature, including 7% with limy bile in both the GB and CBD.3 Tsukamoto et al.4 reported 26 cases in which obstructive jaundice was accompanied by limy bile. In cases with biliary symptoms accompanying limy bile, laparoscopic cholecystectomy is a less invasive option than open surgery, and its safety has been established.5 Nevertheless, patients still incur the risks associated with general anesthesia and longer hospital admission period.
We experienced a case of limy bile with acute cholangitis and cholecystitis that was treated with endoscopy without surgical intervention.
A 45-year-old female presented in the outpatient department with right upper quadrant pain, fever, and chills for 3 days duration. She did not have a specific medical treatment history. Laboratory findings were as follows: white blood cell count, 13,200/mm3; total/direct bilirubin, 7.73/5.52 mg/dL; gamma-glutamyl transferase, 797 IU/L; alkaline phosphatase, 232 IU/L; AST/ALT, 348/759 IU/L; and amylase/lipase, 49/32 IU/L.
Computed tomography showed high-density material in a dependent position of the GB and CBD. CBD dilatation was about 1.3 mm (Fig. 1). The patient was diagnosed with obstructive jaundice due to choledocholithiasis, which entails limy bile.
A duodenoscopy revealed diffusely enlarged major papilla. An endoscopic retrograde cholangiography (ERCP) revealed a 14-mm filling defect at the distal CBD. After an endoscopic sphincterectomy (EST), limy bile materials were washed out by sweeping with a balloon catheter (Fig. 2), and we inserted endoscopic nasobiliary drainage (ENBD). After then, clinical finding of the patient was improved dramatically, and surgical treatment such as a laparoscopic cholecystectomy was postponed. Four days after the first ERCP, we repeated the ERCP and again found a filling defect in the distal CBD. After completely removing limy bile from the CBD, we inserted a guide wire into the GB through the cystic duct, and a 7 Fr double-pigtail catheter (length, 15 cm) was introduced to the GB to evacuate limy bile (Fig. 3). The patient recovered completely after the endoscopic procedure.
Six months later, she was admitted for follow-up examination. During the follow up of six months, she was administered daily medication consisting of 600 mg of UDCA (Ursa®; Daewoong, Seoul, Korea) and 300 mg of a terpene preparation (Rowachol®; Rowa Pharma, Cork, Ireland). Laboratory findings were within normal ranges, and follow-up studies, including a CT, showed the complete evacuation of limy bile from the biliary system and GB (Fig. 4). The double-pigtail stent inserted to the GB was removed.
Limy bile is an uncommon condition in which the gallbladder and bile duct are filled with radiopaque material, readily noted on plain radiographs.1,2 Since the first description of this syndrome in 1911 by Churchman, more than 300 cases of limy bile have been reported.3
The presence of limy bile in the CBD is very rare, with only a few reported cases. Thus, when obstructive jaundice occurs with limy bile syndrome, there are no definite treatment guidelines. The most frequently used treatment to date is cholecystectomy; cholecystectomy is performed for limy bile in the GB, and cholecystectomy plus insertion of a T-tube into the CBD after removal of limy bile are performed for limy bile in the GB and the CBD.6 Recently, laparoscopic cholecystectomy for focal limy bile in the gallbladder has been reported,5 and a combined application of EST and laparoscopic cholecystectomy was used to treat limy bile in both the GB and CBD.7
In the present case, we performed EST to treat the cholangitis caused by biliary lithiasis. In most cases of limy bile syndrome, laparoscopic cholecystectomy is a safe procedure for treatment of acute cholecystitis. However, in patients at increased surgical risk, endoscopic drainage such as endoscopic transpapillary gallbladder drainage (ETGD) is an alternative treatment for acute cholecystitis.8,9 Itoi et al.9 reported that among 36 acute cholecystitis patients who received ETGD, 35 showed clinically favorable response without any serious procedure-related complications.
Given that limy bile is a movable precipitant of calcium carbonate combined with cholesterol,10 we postulated that ETGD could be used to drain limy bile and performed ETGD in this patient. Six months after the procedure, we observed complete evacuation of limy bile from the GB. Though surgery is the mainstay of the treatment for limy bile, endoscopic treatment such as EST and/or ETGD may be considered in selective patients, especially a high-risk candidate for operation.